orphan

News

Gilead rescinds orphan status request for COVID-19 drug

Gilead has rescinded its request for orphan status for its potential COVID-19 antiviral remdesivir amid a furore over its pricing should it get to market.

News

Shire plans filing for HAE drug after phase 3 success

Lanadelumab could revolutionise treatment of swelling disease.

News

Scott Gottlieb confirmed as FDA commissioner

Senators vote in favour of president Trump’s pick.

News

European union flag against parliament in Brussels, Belgium

EUSA Pharma approval fills gap in neuroblastoma market

Company can move in after United Therapeutics withdrew its product Unituxin

News

EU regulators back two more orphan drugs, question of pricin...

Two orphan medicines are heading towards the European market, after regulators recommended rare disease drugs from Biogen and BioMarin.

News

Novartis and Allergan to combine drugs in NASH

Swiss pharma also aims for new CAR-T therapy indication.

Gilead rescinds orphan status request for COVID-19 drug

Shire plans filing for HAE drug after phase 3 success

Scott Gottlieb confirmed as FDA commissioner

EUSA Pharma approval fills gap in neuroblastoma market

EU regulators back two more orphan drugs, question of pricin...

Novartis and Allergan to combine drugs in NASH

Iambic prices its IPO, seeking to raise up to $160m

Discover a new era of healthcare panel engagement: Grounded ...

orphan

Editor's Picks